EPIQ Capital Group, LLC

EPIQ Capital Group, LLC has filed trades across 3 companies (mainly through SEC (Form 4)), most often in IRulya Therapeutics Inc., Applied Molecular Transport Inc. and Lucira Health, Inc. We count 48 filings; the first trade dates from 10 May 2019 and the latest from 27 December 2023.

Every open-market trade on record is a purchase: 31 purchases worth €84.8M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Half of the purchases are above €53k and half below. Clusters matter here: 12 out of 25 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 29 December 2023, reports a transaction in Applied Molecular Transport Inc. The latest purchase dates back some time: it was published 1,622 days ago, on 16 May 2022. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.